B. Braun Melsungen AG

LAS VEGAS, Dec. 5, 2024 /PRNewswire/ -- The growing demand for pelvic floor stimulation devices is driven by the rising incidence of urinary incontinence, neurodegenerative diseases, and other conditions. Additionally, the increasing prevalence of risk factors such as diabetes, hypertension, and obesity, which are key contributors to urinary incontinence, is expected to further fuel this demand. Moreover, factors such as the aging population, frequent product launches and approvals, increased demand for home healthcare, and ongoing product innovations are anticipated to support the overall expansion of the pelvic floor stimulation devices market during the forecast period from 2024 to 2030. DelveInsight's Pelvic Floor Stimulation Devices Market Insights report provides the current and forecast market analysis, individual leading pelvic floor stimulation devices companies' market shares, challenges, pelvic floor stimulation devices market drivers, barriers, trends, and key market pelvic floor stimulation devices companies in the market. Key Takeaways from the Pelvic Floor Stimulation Devices Market Report As per DelveInsight estimates, North America is anticipated to dominate the global pelvic floor stimulation devices market during the forecast period. In the product type segment of the pelvic floor stimulation devices market, the mobile pelvic floor stimulation device category had a significant revenue share in the year 2023. This can be ascribed to the advantages offered by the category. Notable pelvic floor stimulation devices companies such as Medtronic, The Prometheus Group, INNOVO, Shenzhen XFT Medical Limited, Verity Medical Ltd., Tic Medizintechnik GmbH & Co. KG, Laborie, PZmed, TensCare Ltd., Renovia Inc., Novuqare, GymnaUniphy, InControl Medical, Athena Feminine Technologies, Inc., Creo Medical, and several others, are currently operating in the pelvic floor stimulation devices market. In February 2022, Medtronic announced FDA approval for the InterStim X™ system, which delivers sacral neuromodulation (SNM) therapy. These devices are used to treat overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. To read more about the latest highlights related to the pelvic floor stimulation devices market, get a snapshot of the key highlights entailed in the Global Pelvic Floor Stimulation Devices Market Report Pelvic Floor Stimulation Devices Overview Pelvic floor stimulation devices are medical tools designed to strengthen the pelvic floor muscles through electrical stimulation. These devices are commonly used to treat conditions like urinary incontinence, pelvic organ prolapse, and sexual dysfunction, which can occur due to weakened pelvic floor muscles. The devices work by sending mild electrical impulses to the muscles, causing them to contract and gradually become stronger over time. This therapy is non-invasive and can be performed in a clinical setting or at home, offering a convenient and effective solution for people looking to regain control over their pelvic health. In addition to improving muscle strength, pelvic floor stimulation devices can also enhance neuromuscular coordination, helping users gain better awareness and control of their pelvic floor muscles. This is particularly beneficial for women after childbirth or during menopause when the pelvic floor tends to weaken. For men, these devices can help with conditions such as post-prostatectomy incontinence. The devices are generally safe and well-tolerated, although it is important to consult a healthcare provider before starting treatment to ensure it is appropriate for individual needs. Pelvic Floor Stimulation Devices Market Insights In 2023, North America held the largest share of the global pelvic floor stimulation devices market. This is primarily due to factors such as the increasing prevalence of urinary incontinence, particularly among the elderly, and neurodegenerative diseases. Additionally, various initiatives by governments and nonprofit organizations are driving market growth in the region. The demand for advanced technology and a growing number of regulatory approvals are further contributing to this growth. Moreover, the rise in neurodegenerative diseases like Alzheimer's is fueling demand for pelvic floor stimulation devices. Ongoing product development activities in North America are expected to further boost market expansion. To know more about why North America is leading the market growth in the pelvic floor stimulation devices market, get a snapshot of the Pelvic Floor Stimulation Devices Market Outlook Pelvic Floor Stimulation Devices Market Dynamics The global pelvic floor stimulation devices market has experienced notable growth due to rising awareness about pelvic floor disorders, such as urinary incontinence, pelvic organ prolapse, and fecal incontinence. These conditions affect millions of individuals, particularly women post-childbirth and older adults. The increasing focus on women's health, coupled with advancements in non-invasive treatments, has driven demand for pelvic floor stimulation devices, which offer a more effective and less invasive treatment compared to surgeries. The devices work by delivering electrical stimulation to strengthen the pelvic floor muscles, offering relief and improving the quality of life for many patients. A key market driver is the growing aging population, particularly in regions like North America, Europe, and parts of Asia. With aging comes a higher prevalence of pelvic floor dysfunction due to muscle weakening and other health conditions. Additionally, the increasing incidence of obesity and sedentary lifestyles has exacerbated the problem, further boosting the demand for solutions like pelvic floor stimulators. Technological advancements, such as wireless and portable devices, have also enhanced user convenience, driving adoption in home healthcare settings. However, the market is not without challenges. One significant barrier is the lack of awareness and societal stigma surrounding pelvic floor disorders, which may prevent individuals from seeking treatment. Moreover, the high costs associated with certain devices and limited insurance coverage for non-invasive treatments can restrict access to these devices for some patients, particularly in developing regions. Addressing these issues will be critical for sustained market growth. Despite these hurdles, there is significant growth potential for the pelvic floor stimulation devices market. Ongoing research and development efforts are focused on improving device efficacy and user experience, and the rise of telehealth and digital health platforms could expand access to these devices. Additionally, increasing collaborations between manufacturers and healthcare providers, along with government initiatives aimed at improving women's health, are likely to further propel market growth in the coming years. Get a sneak peek at the pelvic floor stimulation devices market dynamics @ Pelvic Floor Stimulation Devices Market Dynamics Analysis Pelvic Floor Stimulation Devices Market Assessment Pelvic Floor Stimulation Devices Market Segmentation Pelvic Floor Stimulation Devices Market Segmentation By Product Type: Fixed and Mobile Pelvic Floor Stimulation Devices Market Segmentation By Application: Urinary Incontinence, Neurodegenerative Diseases, Sexual Dysfunction, and Others Pelvic Floor Stimulation Devices Market Segmentation By End User: Hospitals & Clinics, Homecare Settings, and Others Pelvic Floor Stimulation Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the pelvic floor stimulation devices market are set to emerge as the trendsetter explore @ Pelvic Floor Stimulation Devices Companies Table of Contents Interested in knowing the pelvic floor stimulation devices market by 2030? Click to get a snapshot of the Pelvic Floor Stimulation Devices Market Trends Related Reports Pelvic Floor Disorders Treatment Devices Market Pelvic Floor Disorders Treatment Devices Market Insight, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key pelvic floor disorders treatment devices companies, including Ethicon US, LLC, Boston Scientific Corporation, Coloplast Ltd., Medtronic, CooperSurgical Inc., Cook, MEDGYN PRODUCTS, INC., Personal Medical Corp., Dr. Arabin GmbH & Co. KG, Integra LifeSciences Corporation, Panpac Medical Corp, medesign I.C. GmbH, Zynex Inc., TensCare Ltd., Verity Medical Ltd., InControl Medical, The Prometheus Group, Laborie, Inc., ActivLife Technologies, Athena Feminine Technologies, Atlantic Therapeutics, Renovia Inc., among others. Stress Urinary Incontinence Devices Market Stress Urinary Incontinence Devices Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key stress urinary incontinence devices companies, including Boston Scientific Corporation, AscentX Medical Inc., Coloplast Corporation, Becton, Dickinson and Company, ConvaTec Group PLC, Ethicon US, LLC (Johnson & Johnson), Cook Medical Inc., Teleflex Incorporated, Caldera Medical Inc., Prosurg, Inc., Laborie, InControl Medical, Cousin Surgery, Hollister Incorporated, ZSI Surgical Implants, Atlantic Therapeutics, Flexicare (Group) Limited, A.M.I. GmbH, Axonics, Inc., Betatech Medical, among others. Urinary Incontinence Devices Market Urinary Incontinence Devices Market Insights, Competitive Landscape, and Market Forecast – 2030 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key urinary incontinence devices companies, including NeoTract, Inc, Cook Medical Inc, C.R. Bard Inc, Coloplast Corporation, Boston Scientific Corporation, Ethicon US, LLC, Medtronic PLC, A.M.I. Ltd, Teleflex Incorporated, Hollister Incorporated, ConvaTec Group PLC, Caldera Medical Inc, Prosurg, Inc, Laborie, Inc, Becton, Dickinson and Company, ZSI Surgical Implants, Atlantic Therapeutics, B. Braun Melsungen AG, Flexicare Group Limited, InControl Medical, among others. Fecal Incontinence Market Fecal Incontinence Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key fecal incontinence companies, including Palette Life Sciences, Cook MyoSite, 9 Meters Biopharma, among others. About DelveInsight DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Contact Us Shruti Thakur [email protected] +14699457679 Logo: SOURCE DelveInsight Business Research, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

DUBLIN--( BUSINESS WIRE )--The "Pain Management Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global market for Pain Management Devices is estimated at US$5.1 billion in 2024 and is anticipated to post a CAGR of 8.4% during the 2024-2030 analysis period and stand at a projected US$8.3 billion by 2030. This global report on Pain Management Devices analyzes the market based on type, application, and end-users. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing. Neuromodulation and neurostimulation devices, such as spinal cord stimulators (SCS), deep brain stimulators (DBS), and vagus nerve stimulators, apply electrical impulses to disrupt pain signals. Electrical stimulators, such as TENS and NMES, offer pain relief by sending electrical currents to the skin or muscles, while ablation devices like radiofrequency and cryoablation target and eliminate tissues that cause pain. Furthermore, analgesic Infusion pumps provide controlled amounts of medication directly to the area experiencing pain. The pain management devices market is primarily driven by the rising incidence of chronic diseases, such as cancer and heart disease, which often lead to severe pain and increased demand for effective pain management solutions. The rise in surgical procedures further propels this market, as these devices are essential for providing anesthesia, controlling pain during and after surgery, and facilitating faster recovery. The aging population, who are more vulnerable to chronic pain and surgical procedures, further boosts the demand for these devices. Growing awareness among consumers regarding pain management devices and technological advancements improve both the efficacy and availability of these solutions, resulting in better usage in treating conditions such as cancer pain, arthritis, and neuropathic pain. The pain rehabilitation centers and government initiatives to improve pain management options further contribute to market growth. North America leads the global pain management devices market, cornering the share of 47.9% in 2024, driven by the rapid adoption of devices, rising per capita income, and increasing demand for drug-free therapies during a rising prevalence of chronic pain conditions. This region's market growth is supported by high rates of chronic diseases, a rising geriatric population, established vendors, and favorable reimbursement policies. In contrast, the Asia-Pacific region is projected to be the fastest growing market with a CAGR of 9.8% during the analysis period 2024-2030, fueled by developing healthcare infrastructure, increasing awareness of electrical stimulation techniques, and the penetration of established market players, with India and China poised for the fastest growth due to large patient populations and heightened demand for modern medical facilities. Pain Management Devices Market Analysis by Type The neuromodulation and neurostimulation devices segment is expected to hold a 41.8% market share in 2024, leading the pain management devices market due to clinical validations, an increase in chronic pain disorders, a rise in neurological disorders, an aging population, and a preference for minimally invasive alternatives to traditional surgery. Techniques like spinal cord and peripheral nerve stimulation effectively treat conditions such as neuropathic pain and fibromyalgia, enhancing patients' quality of life while reducing opioid dependence. On the other hand, the ablation devices segment is expected to record the fastest CAGR of 9.2% during the forecast period 2024-2030, driven by their use in pain management and oncology, especially for patients with multiple tumors. Among the various types of ablation devices, radiofrequency ablation is expected to demonstrate the most rapid growth due to its efficacy in managing chronic pain and its widespread application in surgical oncology and other medical areas. Pain Management Devices Market Analysis by Application The neuropathic pain segment leads the pain management devices application market in 2024, with an estimated 29.7% market share, driven by an increasing incidence of conditions such as diabetes, HIV, multiple sclerosis, and cancer, along with advancements in pain management technology. Neuropathic pain is a chronic disorder resulting from somatosensory nervous system injury, necessitating effective treatments like spinal cord stimulation and peripheral nerve stimulation. Increased industry initiatives and the demand for effective pain management options further bolster this segment's dominance. Meanwhile, the cancer pain segment is projected to grow at the fastest CAGR of 9.1% during the 2024-2030 analysis period, fueled by the rising number of cancer patients and the need for devices to alleviate pain associated with nerve compression from tumors, including cases of genetic disorders like Acute Lymphoblastic Leukemia (ALL). Pain Management Devices Market Analysis by End-User The Hospitals & Clinics segment is the largest end-user market in pain management devices, accounting for a share of 51.2% in 2024 due to the increasing use of pain management devices for various conditions and an emphasis on handling post-surgical pain. On the other hand, the Homecare segment is anticipated to experience rapid growth, with a CAGR of 9.6% from 2024 to 2030, fueled by the increasing occurrence of chronic diseases, an aging population, and technological advancements. Patients opt to manage pain at home for convenience and privacy, using easy-to-use devices such as TENS units, which decrease healthcare costs linked to frequent hospital visits. Key Attributes: Report Attribute Details No. of Pages 261 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $5.1 billion Forecasted Market Value (USD) by 2030 $8.3 billion Compound Annual Growth Rate 8.4% Regions Covered Global Pain Management Devices Report Scope Pain Management Devices Key Players Abbott Laboratories Avanos Medical, Inc. B. Braun Melsungen AG. Baxter International Inc. Becton, Dickinson and Company (BD) Boston Scientific Corporation Enovis Corporation ICU Medical, Inc. Johnson & Johnson Kimberly-Clark Corporation LivaNova, plc Medtronic plc Nevro Corp. OMRON Healthcare, Inc. Pfizer Inc. SPR Therapeutics, Inc. Stimwave LLC Stryker Corporation Key Metrics Historical Period: 2021-2023 Base Year: 2023 Forecast Period: 2024-2030 Units: Value market in US$ Pain Management Devices Market by Geographic Region North America (The United States, Canada, and Mexico) Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe) Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific) South America (Brazil, Argentina, and Rest of South America) Rest of World Pain Management Devices Market by Type Neuromodulation & Neurostimulation Devices Ablation Devices Analgesic Infusion Pumps Electrical Stimulation Devices Pain Management Devices Market by Application Neuropathic Pain Musculoskeletal Pain Cancer Pain Facial & Migraine Pain Other Applications (Including Brain, Trauma, Menstrual Pain, Postoperative Pain, Pediatric Pain, Geriatric Pain and others) Pain Management Devices Market by End-User Hospitals and Clinics Rehabilitation Centers Home Care Settings For more information about this report visit https://www.researchandmarkets.com/r/lpdnjx About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Baxter announced this week that it has restarted the highest-throughput IV solutions manufacturing line at its North Cove plant in Marion, North Carolina. Before Hurricane Helene’s devastating remnants hit western North Carolina in late September with heavy rain and flooding, the line represented roughly a quarter of the site’s total production and about half of the site’s production of 1-liter IV solutions that hospitals and clinics most commonly use. Since the North Cove plant went offline, hospitals across the country have faced disruption in the supply of some sterile intravenous fluids used in everything from intravenous dialysis care to some surgeries. The 1.4 million-ft² facility employs 2,500 people and is the largest manufacturer of intravenous and peritoneal dialysis products in the U.S., according to Baxter. Baxter says its goal remains to return to 90% to 100% allocation of certain IV solution product codes for U.S. customers by the end of the year. The company also recently announced: The first temporary bridge at the North Cove site has already transported more than 885 truckloads of finished products off-site and to customers. Baxter has started to expand support for new peritoneal dialysis patients on a limited basis, with a the goal of returning to pre-Helene levels for new patient starts by the end of 2024. The Baxter International Foundation has donated roughly $4 million to support employees and communities impacted by Hurricane Helene. Other medtech companies including B. Braun Medical and Fresenius Medical Care have also responded to the shortage. In a statement, U.S. Health and Human Services Secretary Xavier Becerra described Baxter’s progress at North Cove as encouraging. “The output from the restarted line, which will be closely monitored to help ensure the quality and safety of released product, will supplement product that is being imported from abroad in accordance with temporary grants of regulatory flexibility from FDA,” Becerra said. “While important steps remain to ensure the safety of this production, this latest development moves us another step closer to ensuring partners and patients have access to the quality supplies they need. I look forward to continued progress in the coming weeks.” Related: An even larger medtech supply chain shock looms beyond the pandemic